Chromoplectic TPM3–ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib

BACKGROUND: Inflammatory myofibroblastic tumors (IMTs) are rare sarcomas that can occur at any age. Surgical resection is the primary treatment for patients with localized disease; however, these tumors frequently recur. Less commonly, patients with IMTs develop or present with metastatic disease. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansfield, A. S., Murphy, S. J., Harris, F. R., Robinson, S. I., Marks, R. S., Johnson, S. H., Smadbeck, J. B., Halling, G. C., Yi, E. S., Wigle, D., Vasmatzis, G., Jen, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091324/
https://www.ncbi.nlm.nih.gov/pubmed/27742657
http://dx.doi.org/10.1093/annonc/mdw405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091324/
https://www.ncbi.nlm.nih.gov/pubmed/27742657
http://dx.doi.org/10.1093/annonc/mdw405

Ejemplares similares